- Home
- CENX vs GNLX Comparison
CENX vs GNLX Comparison
Compare CENX & GNLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CENX
- GNLX
- Stock Information
- Founded
- CENX 1995
- GNLX 2001
- Country
- CENX United States
- GNLX United States
- Employees
- CENX N/A
- GNLX N/A
- Industry
- CENX Aluminum
- GNLX Biotechnology: Pharmaceutical Preparations
- Sector
- CENX Industrials
- GNLX Health Care
- Exchange
- CENX Nasdaq
- GNLX Nasdaq
- Market Cap
- CENX N/A
- GNLX 103.6M
- IPO Year
- CENX 1996
- GNLX 2023
- Fundamental
- Price
- CENX $18.33
- GNLX $2.27
- Analyst Decision
- CENX Buy
- GNLX Strong Buy
- Analyst Count
- CENX 3
- GNLX 4
- Target Price
- CENX $21.00
- GNLX $18.25
- AVG Volume (30 Days)
- CENX 915.2K
- GNLX 141.5K
- Earning Date
- CENX 11-04-2024
- GNLX 11-14-2024
- Dividend Yield
- CENX N/A
- GNLX N/A
- EPS Growth
- CENX N/A
- GNLX N/A
- EPS
- CENX 3.19
- GNLX N/A
- Revenue
- CENX $2,101,699,999.00
- GNLX $8,000.00
- Revenue This Year
- CENX N/A
- GNLX N/A
- Revenue Next Year
- CENX $12.05
- GNLX N/A
- P/E Ratio
- CENX $5.78
- GNLX N/A
- Revenue Growth
- CENX N/A
- GNLX N/A
- 52 Week Low
- CENX $9.65
- GNLX $1.60
- 52 Week High
- CENX $25.39
- GNLX $16.60
- Technical
- Relative Strength Index (RSI)
- CENX 31.86
- GNLX 38.68
- Support Level
- CENX $23.25
- GNLX $2.13
- Resistance Level
- CENX $24.22
- GNLX $2.80
- Average True Range (ATR)
- CENX 1.14
- GNLX 0.20
- MACD
- CENX -0.68
- GNLX -0.04
- Stochastic Oscillator
- CENX 8.67
- GNLX 14.21
About GNLX Genelux Corporation
Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec) and others.